Needham & Company Reiterates a 'Buy' on Ceradyne (CRDN); Mgmt Reaffirms Full-Year Guidance At Investor Conference
Tweet Send to a Friend
Needham & Company reiterates a 'Buy' rating on Ceradyne (Nasdaq: CRDN), price target $27.
Needham analyst says, "CRDN shares, which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst says, "CRDN shares, which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
